Medical device licence · 94809 · Class 3
RESTYLANE DEFYNE
Yes: licensed in Canada
Licence status Issued (active); first licensed March 6, 2015. It is in Health Canada’s list of active licences.
- Licence number
- 94809
- Licence holder
- Q-Med AbUppsala, Sweden
- Risk class
- Class III (moderate to high risk)
- Licence type
- Device Group Family
- First licensed
- March 6, 2015
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- RESTYLANE DEFYNE
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.